Anne Moxhon

Phase II Study of Sunitinib in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: GORTEC 2006-01

Jean‐Pascal Machiels, Stéphanie Henry, Sylvie Zanetta et al. · Journal of Clinical Oncology · 2009 · 170 citations · Full text

Medicine, Oncology, Pharmacology +17

ADJUVANT RADIATION THERAPY DOES NOT CAUSE URINARY INCONTINENCE AFTER RADICAL PROSTATECTOMY: RESULTS OF A PROSPECTIVE RANDOMIZED STUDY

Paul J. Van Cangh, Françoise Richard, Francis Lorge et al. · The Journal of Urology · 1998 · 138 citations

Medicine, Surgery, Urology +16

Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02)

Sandra Schmitz, M.-C. Kaminsky-Forrett, Stéphanie Henry et al. · Annals of Oncology · 2012 · 77 citations · Full text

Medicine, Oncology, Metastasis +13

Panitumumab as a radiosensitizing agent in KRAS wild-type locally advanced rectal cancer

F. Mardjuadi, Javier Carrasco, Jean-Charles Coche et al. · Targeted Oncology · 2014 · 20 citations · Full text

Medicine, Oncology, Pharmacology +12

Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: GORTEC 2008-02.

Sandra Schmitz, M.-C. Kaminsky-Forrett, Stéphanie Henry et al. · Journal of Clinical Oncology · 2010 · 14 citations

Medicine, Oncology, Pharmacology +15